Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Health Science Reports
|
September 25, 2025
Combining Real-World and Clinical Trial Data Through Privacy-Preserving Record Linkage: Opportunities and Challenges-A Narrative Review
Michael Batech, Ann Madsen, Nicolle Gatto, et al.
Molecular Genetics and Metabolism
|
May 1, 2025
Metabolic decompensation events among patients with propionic acidemia across the US: A large electronic medical record data study
Vanja Sikirica, Geetanjoli Banerjee, Sue Perera, et al.
Vaccines
|
February 26, 2025
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States
Mawuli Nyaku, Lara S Yoon, Deborah Ricci, et al.
The Journal of Rheumatology
|
November 16, 2021
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R Curtis, Xiaofeng Zhou, David T Rubin, et al.
RMD Open
|
May 28, 2021
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
Gerd R Burmester, Peter Nash, Bruce E Sands, et al.
Plant Physiology
|
March 11, 2014
Biodesalination: a case study for applications of photosynthetic bacteria in water treatment
Jaime M Amezaga, Anna Amtmann, Catherine A Biggs, et al.
RMD Open
|
October 31, 2020
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Stanley B Cohen, Yoshiya Tanaka, Xavier Mariette, et al.
Advances in Therapy
|
October 9, 2020
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis
Stanley B Cohen, Jeffrey D Greenberg, James Harnett, et al.
Annals of the Rheumatic Diseases
|
August 8, 2020
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
Philip Mease, Christina Charles-Schoeman, Stanley Cohen, et al.
JAMA Network Open
|
September 30, 2024
Calibrating Observational Health Record Data Against a Randomized Trial
David Merola, Ulka Campbell, David Lenis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Health Science Reports
|
September 25, 2025
Combining Real-World and Clinical Trial Data Through Privacy-Preserving Record Linkage: Opportunities and Challenges-A Narrative Review
Michael Batech, Ann Madsen, Nicolle Gatto, et al.
Molecular Genetics and Metabolism
|
May 1, 2025
Metabolic decompensation events among patients with propionic acidemia across the US: A large electronic medical record data study
Vanja Sikirica, Geetanjoli Banerjee, Sue Perera, et al.
Vaccines
|
February 26, 2025
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States
Mawuli Nyaku, Lara S Yoon, Deborah Ricci, et al.
The Journal of Rheumatology
|
November 16, 2021
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R Curtis, Xiaofeng Zhou, David T Rubin, et al.
RMD Open
|
May 28, 2021
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
Gerd R Burmester, Peter Nash, Bruce E Sands, et al.
Plant Physiology
|
March 11, 2014
Biodesalination: a case study for applications of photosynthetic bacteria in water treatment
Jaime M Amezaga, Anna Amtmann, Catherine A Biggs, et al.
RMD Open
|
October 31, 2020
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Stanley B Cohen, Yoshiya Tanaka, Xavier Mariette, et al.
Advances in Therapy
|
October 9, 2020
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis
Stanley B Cohen, Jeffrey D Greenberg, James Harnett, et al.
Annals of the Rheumatic Diseases
|
August 8, 2020
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
Philip Mease, Christina Charles-Schoeman, Stanley Cohen, et al.
JAMA Network Open
|
September 30, 2024
Calibrating Observational Health Record Data Against a Randomized Trial
David Merola, Ulka Campbell, David Lenis, et al.
Page
of 4